These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Summary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults. Ann Intern Med; 2023 Feb; 176(2):I24. PubMed ID: 36592458 [No Abstract] [Full Text] [Related]
8. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis. Horning JA; Czajka J; Uhl RL Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565 [No Abstract] [Full Text] [Related]
9. Fracture Risk During and After Bisphosphonate Drug Holidays: A Matter of Methods? Adams AL Med Care; 2020 May; 58(5):417-418. PubMed ID: 32149922 [No Abstract] [Full Text] [Related]
10. The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density. van der Burgh AC; de Keyser CE; Zillikens MC; Stricker BH Drugs; 2021 Nov; 81(16):1831-1858. PubMed ID: 34724173 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate drug holidays: One size does not fit all. DiGiulio M; Loveless T; Heider G; Fagan K; Porsche B Nurse Pract; 2020 Mar; 45(3):50-55. PubMed ID: 32068658 [TBL] [Abstract][Full Text] [Related]
12. Contradicting the evidence for bisphosphonate therapy. Vrecko DE Can Fam Physician; 2014 Jul; 60(7):611. PubMed ID: 25022631 [No Abstract] [Full Text] [Related]
13. Atypical fractures and molecular environment: What do we know? Elniel AR; Giannoudis PV Injury; 2018 Nov; 49(11):1953-1958. PubMed ID: 30366688 [No Abstract] [Full Text] [Related]
14. Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review. Fink HA; MacDonald R; Forte ML; Rosebush CE; Ensrud KE; Schousboe JT; Nelson VA; Ullman K; Butler M; Olson CM; Taylor BC; Brasure M; Wilt TJ Ann Intern Med; 2019 Jul; 171(1):37-50. PubMed ID: 31009947 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates for the prevention and treatment of osteoporosis. Maraka S; Kennel KA BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528 [TBL] [Abstract][Full Text] [Related]
16. Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE. Black DM; Thompson AR; Eastell R; Bouxsein ML Lancet Diabetes Endocrinol; 2024 Jun; 12(6):371-373. PubMed ID: 38677307 [No Abstract] [Full Text] [Related]
17. OSTEOPOROTIC FRACTURES DURING BISPHOSPHONATE DRUG HOLIDAY. Bindon B; Adams W; Balasubramanian N; Sandhu J; Camacho P Endocr Pract; 2018 Feb; 24(2):163-169. PubMed ID: 29144808 [TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk. Nayak S; Greenspan SL Osteoporos Int; 2019 Apr; 30(4):705-720. PubMed ID: 30623214 [TBL] [Abstract][Full Text] [Related]
19. How to use bisphosphonates safely and optimally. Jagpal A; Saag KG Rheumatology (Oxford); 2018 Nov; 57(11):1875-1876. PubMed ID: 29165674 [No Abstract] [Full Text] [Related]
20. Can the bisphosphonate I'm taking for osteoporosis actually cause a bone fracture? Johns Hopkins Med Lett Health After 50; 2011 Oct; 23(8):7. PubMed ID: 22059260 [No Abstract] [Full Text] [Related] [Next] [New Search]